France Patient Monitoring Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

France Patient Monitoring Market Analysis

The France Patient Monitoring Market size is estimated at USD 2.32 billion in 2024, and is expected to reach USD 3.42 billion by 2029, growing at a CAGR of 8.01% during the forecast period (2024-2029).

The COVID-19 pandemic significantly impacted market growth. The demand for wearable devices and patient monitoring devices has increased during the pandemic period as they allow contactless communication and tracking of medical conditions by clinicians. The spread and early diagnosis of COVID-19 can be determined through the remote monitoring of vital signs such as skin and body temperature, respiratory rate, pulse rate, heart rate, and blood oxygen level, which are related to COVID-19. This is anticipated to have a positive effect on the growth of the studied market. For instance, an article published in the European Journal of Digital Health in September 2021 observed that the adoption of multiparametric remote monitoring systems increased in the country during the pandemic, and the patients were equipped with these systems, which included either a tablet or smartphone connected via Bluetooth to a body weight scale and a blood pressure monitor. Moreover, the rising company activities for developing technologically advanced products and increasing product launches and approvals in the country have increased its adoption among consumers. For instance, in April 2022, Schiller France launched an MRI-compatible patient monitoring platform, MAGLIFE RT-1, that allows the close monitoring of the patients, including adults, children, and neonates, during the examination and can be fully controlled from outside through MAGSCREEN RT-1. Thus, with such developments, the studied market is expected to regain its full potential in the coming three to four years.

Factors such as the rising burden of chronic diseases and technological advancements in the products are boosting market growth. For instance, according to GLOBOCAN 2020 report, about 579,388 new cancer cases are expected to be diagnosed in France by 2040. Thus, the expected increase in the number of people suffering from cancer is expected to create demand for remote patient monitoring devices, thereby propelling the market growth. Also, according to the study published in PLOS One in January 2021 in France, there were 2.6 million people with chronic obstructive pulmonary disease (COPD), and by 2025, that number is expected to rise to 2.8 million.

The rising population in the country is likely to contract various chronic diseases such as cancer, cardiovascular diseases, diabetes, hypertension, respiratory changes, and other diseases due to lifestyle changes as well as environmental changes. This is expected to increase the adoption of monitoring devices to regularly monitor their condition and status, thereby propelling the growth of the studied market. For instance, according to the 2022 statistics published by UNPF, about 61% of the population living in France was aged between 15-64 years this year. In addition, as per the same source, about 21% of the population was aged 65 years.

The growing government initiatives on digitalization will lead to the development of technologically advanced patient monitoring devices, which in turn is anticipated to fuel the market growth. For instance, in October 2021, the Government of France invested EUR 650 million (USD 690 million) to accelerate the national digital health strategy as part of the Health Innovation 2030 plan. Such initiatives will provide digital patient monitoring device manufacturers a boost, resulting in the introduction of innovative patient monitoring products, thereby propelling the market growth.

Furthermore, the rising company activities in developing advanced patient monitoring devices are also contributing to the market growth. For instance, in November 2022, BIOSENCY signed a partnership with RestMed to expand its development in France. Under this partnership, RestMed distributes BIOSENCY's Bora-Care, a telemonitoring device for homecare patients with respiratory insufficiency, in France. Therefore, owing to the aforementioned factors, the studied market is expected to grow over the forecast period. However, the high cost of technology is likely to impede the growth of the patient monitoring devices market in France over the forecast period.

France Patient Monitoring Market Trends

The Neurology Segment is Expected to Show a Healthy Growth in the France Patient Monitoring Market Over the Forecast Period

France Patient Monitoring Industry Segmentation

As per the scope of this report, patient monitoring devices are the monitoring devices that continuously monitor the patient's vital parameters, such as blood pressure and heart rate, by using a medical monitor and collecting medical (and other) data from individuals.

The France Patient Monitoring Market is Segmented by Device Type (Hemodynamic Monitoring Devices, Neuromonitoring Devices, Cardiac Monitoring Devices, Respiratory Monitoring Devices, and Other Monitoring Devices), Application (Cardiology, Neurology, Respiratory, Fetal and Neonatal, Weight Management and Fitness Monitoring, and Other Applications) and End User (Home Healthcare, Hospitals, and Other End Users). The report offers the value (in USD million) for the above segments.